Article info
PDFPostScript
Letter
Anti-inflammatory capacity of lactobacilli peptidoglycan: mucosal and systemic routes of administration promote similar effects - The Authors' reply
- Correspondence to Corinne Grangette, Center for Infection and Immunity of Lille (CIIL), Institut Pasteur de Lille (IPL), 1 rue du Pr Calmette, 59019 Lille, France; corinne.grangette{at}ibl.fr
Citation
Anti-inflammatory capacity of lactobacilli peptidoglycan: mucosal and systemic routes of administration promote similar effects - The Authors' reply
Publication history
- First published September 23, 2011.
Online issue publication
October 13, 2016
Article Versions
- Previous version (18 April 2016).
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.